Abstract
The global emergency situation due to SARS-CoV-2 demands the development of fast, reliable and low-cost methods for diagnosing the virus. The diagnostic gold-standard is the RT-PCR (Reverse-Transcription Polymerase Chain Reaction), which requires time, specialized operator and expensive equipment. In contrast, methods based on serological immunoassays may be relatively faster and less exp…